Cerner collaboration to increase access to cancer clinical trials

The company's learning health network t eams with elligo health research and freenome to advance early cancer detection kansas city, mo. , may 18, 2022 /prnewswire/ -- cerner corporation (nasdaq: cern), elligo health research®  and freenome are collaborating to enable a clinical trial through the learning health network to help advance early cancer detection.
CERN Ratings Summary
CERN Quant Ranking